Novel Combined Function Test for Patients on Peritoneal Dialysis

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 2, 2021

Primary Completion Date

October 26, 2023

Study Completion Date

October 26, 2023

Conditions
End Stage Kidney Disease (ESRD)
Interventions
DIAGNOSTIC_TEST

Traditional Peritoneal Equilibrium Test

The first day started with a traditional PET consisting of a 240-minutes dwell with 2.3% glucose PD solutions. The intervention includes sampling of blood plasma (Na, K, glucose, creatinine, urea and albumin) and dialysate (Na, K, glucose, creatinine, urea and albumin).

DIAGNOSTIC_TEST

Combined Peritoneal Equilibrium Test

The PET test on the first day (Day 1) was followed by a short (60 min) combined PET with 4.25% glucose solution. On the second day (Day 2), the combined PET was repeated. The intervention includes sampling of blood plasma (Na, K, glucose, creatinine, urea and albumin) and dialysate (Na, K, glucose, creatinine, urea and albumin).

Trial Locations (1)

Unknown

Hemdialysmottagningen, Skånes Universitetssjukhus (SUS) Lund, Lund

All Listed Sponsors
lead

Lund University

OTHER

NCT06723223 - Novel Combined Function Test for Patients on Peritoneal Dialysis | Biotech Hunter | Biotech Hunter